Hyperplasia, partial hepatectomy, and the carcinogenicity of aflatoxin B1

Journal of Cellular Biochemistry

Volumn 91, Issue 2, 2004, Pages 243-249

  Roebuck, B D ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Aflatoxin B1; Hepatectomy; Hepatic toxicity; Hyperplasia; Liver cancer

Indexed keywords

AFLATOXIN B1; CARCINOGEN;

CARCINOGENESIS; CARCINOGENICITY; CELL HYPERPLASIA; LIVER CANCER; LIVER TOXICITY; MALNUTRITION; PARASITE; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; REVIEW; VIRUS; ANIMAL; BODY WEIGHT; DRUG EFFECT; HYPERPLASIA; LIVER; LIVER REGENERATION; LIVER RESECTION; LIVER TUMOR; PATHOLOGY; RAT;

AFLATOXIN B1; ANIMALS; BODY WEIGHT; CARCINOGENS; HEPATECTOMY; HYPERPLASIA; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; LIVER REGENERATION; RATS;

EID: 5144232856     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.10758     Document Type: Review

References (27)

1. Appleton BS, Campbell TC. 1982. Inhibition of aflatoxin-initiated preneoplastic liver lesions by low dietary protein. Nutr Cancer 3:200-206.
2. 1-induced liver injury through neutrophil-dependent and -independent mechanisms. Toxicol Sci 58:208-215.
3. Bolton MG, Muñoz A, Jacobson LP, Groopman JD, Maxuitenko YY, Roebuck BD, Kenlser TW. 1993. Transient intervention with oltipraz against aflatoxin-induced hepatic tumorigenesis. Cancer Res 53:3499-3404.
4. Busby WF, Wogan GN. 1985. Aflatoxins. In: Searle CE, editor. Chemical carcinogens, vol. 2. Washington, DC: American Chemical Society, pp 946-1093.
5. Cayama E, Tsuda H, Sarma DSR, Farber E. 1978. Initiation of chemical carcinogenesis requires cell proliferation. Nature 275:60-62.
6. Chen CJ, Yu MW, Liaw YF. 1997. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 12:8294-8308.
7. 1 treated rat. Ph.D. Thesis, Johns Hopkins University, Baltimore, MD.
8. El-Serag HB, Mason AC. 1999. Rising incidence of hepatocellular carcinoma in the United States. New Engl J Med 340:745-750.
9. Higgins GM, Anderson RM. 1931. Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 12:186-202.
10. 7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: Role of induction of glutathione S-transferases. Cancer Res 46:3924-3931.
11. Kensler TW, Egner PA, Dolan PM, Groopman JD, Roebuck BD. 1987. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4- methyl-1,2-diothiol-3-thione (oltipraz) and related 1,2-diothiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res 47:4271-4277.
12. Kensler TW, Groopman JD, Eaton DL, Curphey TJ, Roebuck BD. 1992. Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione. Carcinogenesis 13:95-100.
13. Kensler TW, Qian GS, Chen JG, Groopman JD. 2003. Translational strategies for cancer prevention in liver. Nat Rev Cancer 3:321-329.
14. 1 and hepatitis B virus in hepatocarcinogenesis. Liver Int (in press).
15. Kim WR, Brown RS, Terrault NA, El-Serag H. 2002. Burden of liver disease in the United States: Summary of a workshop. Hepatology 36:227-242.
16. 1 in the rat. Toxicol Appl Pharmacol 93:442-451.
17. 1-induced hepatic tumorigenesis. Carcinogenesis 14:2423-2425.
18. Michalopoulos GK, DeFrances MC. 1997. Liver regeneration. Science 276:60-66.
19. Newberne PM, Butler WH. 1969. Acute and chronic effects of aflatoxin on the liver of domestic and laboratory animals: A review. Cancer Res 29:236-250.
20. Pugh TD, King JH, Koen H, Nychka D, Chover J, Wahba G, He Y, Goldfarb S. 1983. Reliable stereological method for estimating the number of microscopic hepatocellular foci from their transections. Cancer Res 43:1261-1268.
21. Roebuck BD, Curphey TJ, Li Y, Baumgartner KJ, Bodreddigari S, Yan J, Gange SJ, Kensler TW, Sutter TR. Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz. Carcinogenesis (in press).
22. 1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): Predictive role for short-term molecular dosimetry. Cancer Res 51:5501-5506.
23. 1 carcinogenesis. Cancer Res 31:491-495.
24. Solt D, Farber E. 1976. New principle for the analysis of chemical carcinogenesis. Nature 263:701-703.
25. Wilson DM, Payne GA. 1994. Factors affecting Aspergillus flavus group infection and aflatoxin contamination of crops. In: Eaton DL, Groopman JD, editors. The toxicology of aflatoxins: Human health, veterinary, and agricultural significance. Boston: Academic Press, Inc. pp 309-325.
26. Yager JD, Potter VR. 1975. A comparison of the effects of 3′-methyl-4-dimethylaminoazobenzene, 2-methyl-4-dimethylaminoazobenzene, and 2-acetylaminofluorene on rat liver DNA stability and new synthesis. Cancer Res 35:125-1234.
27. Yee SB, Harkema JR, Ganey PE, Roth RA. 2003. The coagulation system contributes to synergistic liver injury from exposure to monocrotaline and bacterial lipopolysaccharide. Toxicol Sci 74:457-469.